Parkman Healthcare Partners »

4d Molecular Therapeutics In shares owned by Parkman Healthcare Partners

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Parkman Healthcare Partners from 13F filings

Historical chart of Parkman Healthcare Partners investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by Parkman Healthcare Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by Parkman Healthcare Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.7M 200k 8.69

More positions owned by Parkman Healthcare Partners

Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Boston Scientific Corporation (BSX)
Alnylam Pharmaceuticals (ALNY)
Insulet Corporation (PODD)
CVS Caremark Corporation (CVS)
Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA)
Miragen Therapeutics (VRDN)
Zimmer Holdings (ZBH)
Stryker Corporation (SYK)
Qiagen Nv Com Shs (QGEN)
McKesson Corporation (MCK)
Danaher Corporation (DHR)
Kalvista Pharmaceuticals (KALV)
Uniqure Nv SHS (QURE)
Neurocrine Biosciences (NBIX)

View all positions for Parkman Healthcare Partners

Top funds holding 4d Molecular Therapeutics In

BVF
RA Capital Management
Goldman Sachs Group
BlackRock
Vanguard Group
Novo A/S
Henderson Group
Federated Investors
Millennium Management
Armistice Capital
Morgan Stanley
Geode Capital Management
State Street Corporation
Assenagon Asset Management
Two Sigma Advisers

View all funds holding 4d Molecular Therapeutics In